BACKGROUND: Osteoarthritis (OA) is a popular arthrosis featured as pain, limited joint activity, and deformity. Cyclooxygenase-2 (COX-2) has been reported to be up-regulated in arthritic tissues and is integral to the progression of osteoarthritis (OA). Previous studies showed the COX-2 promoter G-765C polymorphism could influence COX-2 expression. However, the relationship between the variant and OA risk is contrasting. METHODS: We conducted a case-control study with 196 primary end-stage hip and knee OA cases and 196 controls in a Chinese Han population. Subsequently, we integrated this case-control study in a meta-analysis to acquire greater statistical power. The results from our case-control study using MassARRAY genotyping technology and binary logistic regression statistical methods. RESULTS: The variant carriers in the Chinese Han population had a lower primary end-stage hip and knee OA susceptibility (C vs G: OR = 0.350, 95%CI: 0.154-0.797, P = .012; GC vs GG: adjusted OR = 0.282, 95%CI: 0.118-0.676, P = .005). Stratification studies indicated that a higher GC frequency in women decreased not only knee OA susceptibility but also unilateral knee OA risk. The meta-analysis showed that the variant exhibited a significantly decreased OA risk through comparisons involving allelic, homozygous, heterozygous, and dominant models. CONCLUSION: Our findings suggest that the COX-2 G-765C polymorphism exerts a protective effect against primary end-stage knee osteoarthritis in a female Chinese Han population.
BACKGROUND:Osteoarthritis (OA) is a popular arthrosis featured as pain, limited joint activity, and deformity. Cyclooxygenase-2 (COX-2) has been reported to be up-regulated in arthritic tissues and is integral to the progression of osteoarthritis (OA). Previous studies showed the COX-2 promoter G-765C polymorphism could influence COX-2 expression. However, the relationship between the variant and OA risk is contrasting. METHODS: We conducted a case-control study with 196 primary end-stage hip and knee OA cases and 196 controls in a Chinese Han population. Subsequently, we integrated this case-control study in a meta-analysis to acquire greater statistical power. The results from our case-control study using MassARRAY genotyping technology and binary logistic regression statistical methods. RESULTS: The variant carriers in the Chinese Han population had a lower primary end-stage hip and knee OA susceptibility (C vs G: OR = 0.350, 95%CI: 0.154-0.797, P = .012; GC vs GG: adjusted OR = 0.282, 95%CI: 0.118-0.676, P = .005). Stratification studies indicated that a higher GC frequency in women decreased not only knee OA susceptibility but also unilateral knee OA risk. The meta-analysis showed that the variant exhibited a significantly decreased OA risk through comparisons involving allelic, homozygous, heterozygous, and dominant models. CONCLUSION: Our findings suggest that the COX-2G-765C polymorphism exerts a protective effect against primary end-stage knee osteoarthritis in a female Chinese Han population.
Authors: Tadeusz Pietras; Janusz Szemraj; Michał Panek; Andrzej Witusik; Maciej Banasiak; Adam Antczak; Paweł Górski Journal: Mol Biol Rep Date: 2011-06-08 Impact factor: 2.316
Authors: Anastasia Papafili; Michael R Hill; David J Brull; Robin J McAnulty; Richard P Marshall; Steve E Humphries; Geoffrey J Laurent Journal: Arterioscler Thromb Vasc Biol Date: 2002-10-01 Impact factor: 8.311
Authors: Ana M Valdes; Mark Van Oene; Deborah J Hart; Gabriela L Surdulescu; John Loughlin; Michael Doherty; Tim D Spector Journal: Arthritis Rheum Date: 2006-02
Authors: R Altman; G Alarcón; D Appelrouth; D Bloch; D Borenstein; K Brandt; C Brown; T D Cooke; W Daniel; D Feldman Journal: Arthritis Rheum Date: 1991-05
Authors: Cristina Rodriguez-Fontenla; Manuel Calaza; Evangelos Evangelou; Ana M Valdes; Nigel Arden; Francisco J Blanco; Andrew Carr; Kay Chapman; Panos Deloukas; Michael Doherty; Tõnu Esko; Carlos M Garcés Aletá; Juan J Gomez-Reino Carnota; Hafdis Helgadottir; Albert Hofman; Ingileif Jonsdottir; Hanneke J M Kerkhof; Margreet Kloppenburg; Andrew McCaskie; Evangelia E Ntzani; William E R Ollier; Natividad Oreiro; Kalliope Panoutsopoulou; Stuart H Ralston; Yolande F Ramos; Jose A Riancho; Fernando Rivadeneira; P Eline Slagboom; Unnur Styrkarsdottir; Unnur Thorsteinsdottir; Gudmar Thorleifsson; Aspasia Tsezou; André G Uitterlinden; Gillian A Wallis; J Mark Wilkinson; Guangju Zhai; Yanyan Zhu; David T Felson; John P A Ioannidis; John Loughlin; Andres Metspalu; Ingrid Meulenbelt; Kari Stefansson; Joyce B van Meurs; Eleftheria Zeggini; Timothy D Spector; Antonio Gonzalez Journal: Arthritis Rheumatol Date: 2014-04 Impact factor: 10.995